DHB Task Force Review of DoD Biodefense Infrastructure and Biological Research Portfolio

Abstract

In a memorandum dated 3 October 2008, the Surgeon General of the Army LTG Eric B. Schoomaker requested that an Ad Hoc Subcommittee of the Defense Health Board (DHB) be established to review the Department of Defense (DoD) biodefense infrastructure and research portfolio, and specifically address the following three questions: Whether there is a national and/or strategic defense need for the Military Service Departments (MSD) to own and operate an infrastructure in support of mission requirements for defense capabilities (abroad and homeland) for biodefense; Whether the current processes are effective in transferring the results of basic biological research to advanced product development and licensure; Whether the current infrastructure provides scientific or strategic return on investment for previous and current research, design, test and evaluation (RDT and E) efforts.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 29, 2009
Accession Number
AD1034180

Entities

People

  • Gail Wilensky
  • Gregory A. Poland

Organizations

  • Defense Health Board

Tags

DTIC Thesaurus Topics

  • Air Force
  • Biological Factors
  • Biological Products
  • Biological Warfare Agents
  • Department Of Defense
  • Infectious Diseases
  • Medical Personnel
  • Military Research
  • Military Science
  • National Security
  • Organizational Structure
  • Product Development
  • Teamwork
  • Test And Evaluation
  • United States
  • Vaccines
  • Warfare

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Defense Acquisition Program Management
  • Military History of the United States in the 20th Century.